KeifeRx is building upon its extensive clinical experience in neurodegenerative diseases to advance kinase Inhibitors that attack neurodegenerative diseases at their root cause.  Our drug candidates restore autophagy and attack the three pillars of neurodegenerative diseases; microglial-mediated neuroinflammation, toxic protein build up, and vascular damage while restoring cognition. Our robust pipeline of drug candidates is designed for superior brain penetration and potency, representing a potential new generation of treatments for patients in urgent need.